Z79.818
Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Clinical Classification Guidelines
Inclusion Terms
- Long term (current) use of estrogen receptor downregulators
- Long term (current) use of fulvestrant (Faslodex)
- Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
- Long term (current) use of goserelin acetate (Zoladex)
- Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
- Long term (current) use of megestrol acetate (Megace)
Medical Intelligence & Overview
ICD-10 code Z79.818 pertains to the ongoing, long-term use of medications that influence estrogen receptors and estrogen levels in the body. These medications are often prescribed for managing hormone-sensitive conditions, such as certain types of breast or prostate cancer. This code covers a variety of drugs that either activate or suppress estrogen activity, helping doctors monitor and document treatment plans over extended periods.
Causes & Symptoms
Clinical Causes: Treatment of estrogen-sensitive breast cancer Treatment of prostate cancer using hormonal therapy Management of other hormone-related conditions Use of medications like fulvestrant, gonadotropin-releasing hormone (GnRH) agonists, and progestins for long-term therapy
Key Symptoms: Possible side effects related to hormone therapy such as hot flashes or night sweats Bone density loss over time if estrogen levels are significantly altered Changes in menstrual cycles or reproductive functions Symptoms related to hormonal imbalance, including mood swings or fatigue Potential risk of blood clots or cardiovascular issues depending on the medication
Diagnostic & Treatment
Diagnosis Path: Diagnosis of long-term use of estrogen receptor agents is typically based on a comprehensive review of the patient's medical history, medication intake, and ongoing treatment plans. Healthcare providers document the continuous administration of these medications using ICD-10 code Z79.818. Regular monitoring may include blood tests, imaging, and assessments of side effects to ensure safe and effective management of therapy.
Treatment Protocols: While this ICD-10 code is primarily for documentation purposes, the management of patients on long-term estrogen receptor agents involves:
Clinical Advice & FAQs
Billing Guidance
Is Z79.818 a billable ICD-10 code?
Yes, Z79.818 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z79.818?
Clinical documentation must specify the nature of Long term (current) use of other agents affecting estrogen receptors and estrogen levels and any associated comorbidities for accurate reporting.
Cite this Clinical Reference